Comparison of Pre Existing Intra Operative Thyroidectomy Difficulty Score With Novel Difficult Thyroidectomy Predictor Score in Prediction of Difficult Thyroidectomies

NCT ID: NCT07057570

Last Updated: 2025-07-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

136 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-07-01

Study Completion Date

2025-01-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Novel Difficult Thyroidectomy Score to predict Difficult thyroidectomies pre operatively .

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A newer score has been formulated that will help to predict the level of difficulty that surgeon may encouter during any thyroidectomy unlike before where there was no such tool and only intra operatively surgeon realized he has opened a very difficult thyroid case.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Thyroidectomy Thyroid Gland Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

All patients undergoing thyroidectomy

No intervention , just observation

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All MNG undergoing thyroidectomy Euthyroid /toxic controlled cases Age 18-60yrs Both genders

Exclusion Criteria

* carcinomas Co morbs Toxicity signs Pregnancy /lactation
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

King Edward Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kemu

Lahore, Punjab Province, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Umaiya/Kemu

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.